and many of the specialized tests sent to subcontracted labs have been reimbursed
by insurance companies.
In budget-based payment arrangements,
provider organizations will be accountable for the costs of diagnostic testing, including labs,
during all phases of a patient's care, including in the outpatient setting. To succeed in these payment arrangements and
to ultimately improve the value of care for patients, provider organizations will need to develop innovations aimed at improving the appropriateness of test selection and frequency. These tactics will likely differ depending on whether the test is a new, novel, or specialty-focused test or more established, high-volume, routinely ordered test.